PinPoint Get PinPoint on the App Store

Peptides / Compound guide

GHRP-6 guide

GHRP-6 is a synthetic six-amino-acid growth hormone secretagogue studied in human pharmacokinetic research.[2] PinPoint uses the cited elimination reference while explicitly estimating the subcutaneous absorption inputs for its tracking curve.[1]

PINPOINT EDITORIAL · UPDATED 05 OCT 2026
Limited human research · 2.5 h model input

Editorial still life for peptides research guides

ILLUSTRATION / COMPOUND LIBRARY SERIES

At a glance

GHRP-6 library factsPeptides. Routes: subcutaneous. Half-life model input: 2.5 hours. Package: 5 mg / package. Limited human research. CATEGORYROUTES IN LIBRARYHALF-LIFE MODEL INPUTTYPICAL PACKAGERESEARCH STATUS Peptidessubcutaneous2.5 hours5 mg / packageLimited human research SOURCE / PINPOINT COMPOUND LIBRARY

Read the record in context

GHRP-6's reference involves intravenous administration in healthy male volunteers. Its 2.5-hour scalar is source-based in that setting, while subcutaneous absorption parameters are estimates. The historical 5 mg package shown above remains an unverified library snapshot; the supplier link no longer substantiates a worked example.[1]

What the research says

The GHRP-6 pharmacokinetic study enrolled nine healthy male volunteers receiving a single intravenous bolus. Researchers quantified plasma peptide with a validated liquid-chromatography and mass-spectrometry method. Samples supported modeling of an early distribution phase and a slower elimination phase across three studied exposure levels.[2]

The mean distribution half-life was 7.6 minutes, whereas elimination half-life averaged 2.5 hours. These are separate parameters from a two-phase model, not competing descriptions of one event. The investigators also observed unusual concentration spikes during elimination in four participants, adding variability to the measured profiles.[2]

The source establishes human intravenous disposition; subcutaneous absorption remains an extrapolation in the library. A separate combination-regimen publication concerns GHRP-6 together with other secretagogues, so it cannot isolate the kinetics of GHRP-6 alone. The guide retains that distinction when presenting the stored tracking input.[2][3][1]

Cited amounts

The original supplier package could not be independently verified from an accessible product document. Its historical amount remains in At a glance as a literal library snapshot. No externally verified package total or package-based preparation calculation is presented here.[1]

Open the calculator for amount conversions

Half-life and timing

Two and a half hours place the second model halving at five hours and the fourth at ten hours. Five intervals total 12.5 hours and leave 3.125% of the starting quantity. This sequence uses an intravenous elimination reference without recreating a subcutaneous absorption phase. The source does not supply that phase's bioavailability or peak time. A diagram can explain the scalar faithfully while still lacking the evidence to portray a directly measured complete subcutaneous profile or select an administration interval.[1][6]

GHRP-6: modeled fraction over five half-livesStarting at 100 percent, the model halves each 2.5 hours. After 12.5 hours, 3.125 percent remains. This is arithmetic, not a measured concentration. ELAPSED HOURS / MODELED STARTING AMOUNT 0 h100%2.5 h50%5 h25%7.5 h12.5%10 h6.25%12.5 h3.125% Continue to the calculator

Reconstitution

No numerical reconstitution example is supplied because the original catalog input is unverified. Concentration arithmetic requires an independently established compound amount and final liquid volume; the half-life reference supplies neither. A historical library value cannot substitute for a checked package document. The calculator link remains available as a general unit-conversion tool, while this guide leaves the missing external input unresolved instead of presenting a plausible quantity as verified.[1]

No verified package example
Open GHRP-6 conversion math

Tracking it in PinPoint

From a reference to a record

Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Enter vial size in mg, mcg, or IU and water volume for instant concentration and syringe units. Track vials and prefilled pens side by side.[5]

The Home curve models your levels between doses from published half-life data. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.

Get PinPoint on the App Store

Frequently asked questions

What does the GHRP-6 half-life source measure?
It reports intravenous elimination in healthy male volunteers, represented by a 2.5-hour mean in the library. The subcutaneous curve adds estimated absorption inputs. The guide does not present the full curve as directly measured by that intravenous study.[1][2]
Does the GHRP-6 half-life establish a liquid concentration?
The 2.5-hour library input measures time. Concentration instead requires independently verified mass and liquid volume. Because the original supplier listing is unavailable, this page withholds a package-based numerical conversion. A pharmacokinetic paper cannot fill that missing package input.[1][2][6]
Does a separate subcutaneous schedule reference complete the GHRP-6 model?
A schedule describes when research amounts were administered. It does not necessarily measure bioavailability or absorption time to peak. The library continues to label those subcutaneous inputs as estimates rather than attributing them to the intravenous half-life study.[1][6]
Can a peptide tracker app record GHRP-6?
PinPoint's compound library includes GHRP-6. The app description covers logging compound, dose, site, and pain level, as well as viewing modeled levels between recorded doses. The curve uses published reference inputs and does not account for individual variation. The tracker records the schedule entered by its user; it does not choose a dose or recommend a schedule change.[1][5]

Sources

Facts and reference links were retrieved from the PinPoint application library on 5 October 2026. Links below preserve the library's citations; a catalog source supports a package amount only. Source references carried from the library have not all been independently reverified. Arithmetic examples are identified separately from clinical evidence.

  1. PinPoint compound library, GHRP-6Snapshot of the application library; its references and uncertainty are retained below.Retrieved 2026-10-05 · library
  2. PubMed pharmacology reference 23099431Identity and research summary checked against this document on 5 October 2026. PubMed abstract, retrieved through NCBI EFetch.Retrieved 2026-10-05 · library-reference
  3. Published review PMC5675260Identity and research summary checked against this document on 5 October 2026. Abstract and relevant methods/results or product-monograph sections.Retrieved 2026-10-05 · library-reference
  4. Supplier catalog package referenceUnverified package locator: the supplier site no longer displays the product. The amount is retained only as a library snapshot in At a glance; it is not an externally verified package input.Retrieved 2026-10-05 · unverified-supplier
  5. PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
  6. Unit conversion and exponential-decay arithmeticC = amount / volume; remaining fraction = 2^(-elapsed / half-life). These are illustrations, not measurements.Retrieved 2026-10-05 · arithmetic